Carregant...
Angiotensin blockade or aldosterone blockade as the third neuroendocrine‐blocking drug in mild but symptomatic heart failure patients
Recent clinical trials have explored whether angiotensin receptor blockers (ARBs) or aldosterone blockade should be added to standard angiotensin‐converting enzyme (ACE) inhibitor/β blocker treatment in heart failure. Both strategies are of some value but it is unclear which strategy should be used...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Group
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1861262/ https://ncbi.nlm.nih.gov/pubmed/16339814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2005.068668 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|